SB 1260
Modifies provisions relating to prenatal tests for certain diseases
LR Number:
Last Action:
5/17/2024 - Formal Calendar S Bills for Perfection
Journal Page:
Effective Date:
August 28, 2024

Current Bill Summary

SB 1260 - Currently, a physician or other health care provider shall draw and test a pregnant woman's blood at or soon after her first prenatal examination, with her consent, for syphilis, hepatitis B, or other similar diseases. Under this act, the testing of the pregnant woman's blood shall also occur at the twenty-eighth week of her pregnancy. Additionally, the test shall include hepatitis C and HIV. If a mother tests positive for syphilis, hepatitis B, hepatitis C, or HIV, the physician or other health care provider shall treat the mother in accordance with the most recent accepted medical practice.

Current law requires the Department of Health and Senior Services to work in consultation with the Missouri Genetic Disease Advisory Committee to make rules pertaining to these blood tests. This act repeals the requirement to work with the Committee and requires that the tests be approved or accepted by the U.S. Food and Drug Administration.

This act is substantially similar to a provision in HCS/HB 2413 (2024).



No Amendments Found.